Blade Therapeutics, Inc. — Form D

Blade Therapeutics, Inc. of South San Francisco, CA, a company, filed a Form D exempt-offering notice with the SEC on 2016-06-20. The offering totals $45.4M, of which $27.1M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (22)

NameRoleLocation
Luke EvninDirectorWatertown, MA
Elaine JonesDirectorSOUTH SAN FRANCISCO, CA
Wendye RobbinsDirectorSOUTH SAN FRANCISCO, CA
James ScopaDirectorSan Diego, CA
William SlatteryDirectorBala Cynwyd, PA
Peter Van VlasselaerDirectorNew York, NY
Cameron WheelerDirectorCambridge, MA
Wendye RobbinsExecutive OfficerSOUTH SAN FRANCISCO, CA
Prabha Shirley IbrahimExecutive OfficerSouth San Francisco, CA
William V SlatteryDirectorSouth San Francisco, CA
James B ScopaDirectorSouth San Francisco, CA
Gary B PatouExecutive OfficerSouth San Francisco, CA
Lloyd B KlicksteinDirectorSouth San Francisco, CA
Cameron Shirley WheelerDirectorSouth San Francisco, CA
Peter Shirley Van VlasselaerDirectorSouth San Francisco, CA
Luke Shirley EvninDirectorSouth San Francisco, CA
Wendye Rae RobbinsDirectorSouth San Francisco, CA
Wendye Rae RobbinsExecutive OfficerSouth San Francisco, CA
Rana Rae Al-HallaqDirectorSouth San Francisco, CA
M. Shirley ChiangExecutive OfficerSouth San Francisco, CA
Cameron V WheelerDirectorSouth San Francisco, CA
Peter V Van VlasselaerDirectorSouth San Francisco, CA

Other filings by this issuer (2)

FiledFormOfferingSold
2019-10-24D$24.0M$12.0M
2019-10-24D$50.0M$38.0M

More